Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 140

Blog

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19
COVID-19 | Life Science History | Vaccine

Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19

On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneメs single-dose intranasal vaccine…

Read More Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDル single dose intranasal vaccine candidate for COVID-19Continue

BD received FDA approval for HPV test with extended genotyping capabilities
Biotechnology | Diagnostics | FDA

BD received FDA approval for HPV test with extended genotyping capabilities

On Jul. 22, 2020, BD (Becton, Dickinson) announced that it had received approval for a pre-market approval (PMA)…

Read More BD received FDA approval for HPV test with extended genotyping capabilitiesContinue

Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2
COVID-19 | FDA | Life Science History

Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2

On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…

Read More Pfizer and BioNTech announced agreement with US government for up to 600 million doses of mRNA-based vaccine candidate against SARS-CoV-2Continue

A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment
COVID-19 | Life Science History

A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatment

On Jul. 22, 2020, a new study led by Albert Einstein College of Medicine and Montefiore Health System…

Read More A common blood test identified which COVID-19 patients benefit and which are harmed from steroid treatmentContinue

Secrets of naked mole-rat cancer resistance unearthed
Biotechnology | Disease | Non-Profit Research

Secrets of naked mole-rat cancer resistance unearthed

On Jul. 21, 2020, researchers at the University of Cambridge have shown for the first time that genes…

Read More Secrets of naked mole-rat cancer resistance unearthedContinue

Experimental Coronavirus vaccine is safe and produced immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental Coronavirus vaccine is safe and produced immune response

On Jul. 21, 2020, National Institutes of Health (NIH) researchers reported early results from the first COVID-19 vaccine…

Read More Experimental Coronavirus vaccine is safe and produced immune responseContinue

PerkinElmer released new dried blood spot based COVID-19 serology test
FDA | Life Science History

PerkinElmer released new dried blood spot based COVID-19 serology test

On Jul. 21, 2020, PerkinElmer announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2…

Read More PerkinElmer released new dried blood spot based COVID-19 serology testContinue

GSK and CureVac announced strategic mRNA technology collaboration
Life Science History | Vaccine

GSK and CureVac announced strategic mRNA technology collaboration

On Jul. 21, 2020, GlaxoSmithKline and CureVac announced a strategic collaboration agreement for the research, development, manufacturing and…

Read More GSK and CureVac announced strategic mRNA technology collaborationContinue

Experimental coronavirus vaccine reported safe and produces immune response
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Experimental coronavirus vaccine reported safe and produces immune response

On Jul. 21, 2020, researchers from the National Institutes of Health (NIH) announced that early results from the…

Read More Experimental coronavirus vaccine reported safe and produces immune responseContinue

Mesa Biotech received  $154 million funding from the NIH for accelerated scale-up and deployment
COVID-19 | Life Science History | NIH

Mesa Biotech received $154 million funding from the NIH for accelerated scale-up and deployment

On Jul. 21, 2020, Mesa Biotech announced it had been awarded a contract up to $15.4 million from…

Read More Mesa Biotech received $154 million funding from the NIH for accelerated scale-up and deploymentContinue

Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples
COVID-19 | Life Science History

Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samples

On Jul. 21, 2020, Bio-Techne announced that Exosome Diagnostics, a Bio-Techne brand, had completed validation testing for COVID-19…

Read More Bio-Techne announced launch of ExoCovid-19 test for detection of SARS-CoV-2 In patient samplesContinue

COVID-19 vaccine trials conducted at Washington University, Saint Louis University
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

COVID-19 vaccine trials conducted at Washington University, Saint Louis University

On Jul. 21, 2020, researchers at Washington University School of Medicine in St. Louis and the Saint Louis…

Read More COVID-19 vaccine trials conducted at Washington University, Saint Louis UniversityContinue

BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
Diagnostics | Medical Device | Vaccine

BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations

On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….

Read More BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparationsContinue

Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter
Biotechnology | Pharmaceutical | Therapeutics

Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab Biobetter

On Jul. 20, 2020, Sorrento announced that its partner Mabpharm had received approval of its New Drug Application…

Read More Sorrento Announced Its Partner Mabpharm Has Received Marketing Approval In China For Infliximab BiobetterContinue

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
Life Science History

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial

On Jul. 20, 2020, AstraZeneca announced that Interim results from the ongoing Phase I/II COV001 trial, led by…

Read More COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trialContinue

NIH study showed highly reproducible sex differences in aspects of human brain anatomy
Life Science History

NIH study showed highly reproducible sex differences in aspects of human brain anatomy

On Jul. 20, 2020, a scientific analysis of more than 2,000 brain scans found evidence for highly reproducible…

Read More NIH study showed highly reproducible sex differences in aspects of human brain anatomyContinue

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccine

On Jul. 20, 2020, the Serum Institute of India (SII) announced that with the trials of the COVID-19…

Read More The Serum Institute of India to apply for local trials of Oxford’s COVID-19 vaccineContinue

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
Life Science History

COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial

On Jul. 20, 2020, interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed…

Read More COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trialContinue

FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19
COVID-19 | Life Science History

FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19

On Jul. 20, 2020, Sorrento announced that it had entered into a binding term sheet for an exclusive…

Read More FDA cleared Abivertinib for phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19Continue

Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries
Disease

Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries

On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…

Read More Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countriesContinue

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program
COVID-19 | Life Science History | Vaccine

Valneva confirmed participation in UK Government COVID-19 Vaccine Response Program

On Jul. 20, 2020, Valneva confirmed its participation in the UK government COVID-19 vaccine response program. Valneva had…

Read More Valneva confirmed participation in UK Government COVID-19 Vaccine Response ProgramContinue

Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19
Biotechnology | COVID-19 | Therapeutics

Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19

On Jul. 20, 2020, Mateon Therapeutics announced the launch of its global observational study called ARTI-19, for Artemisinin…

Read More Mateon and Asili Research Alliance entered into partnership for development of Artemisinin against Covid-19Continue

Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line
COVID-19 | Life Science History

Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell line

On Jul. 20, 2020, Innovation Pharma reported receiving new data from ongoing lab testing being conducted at a…

Read More Innovation Pharma’s Brilacidin inhibited novel Coronavirus by almost 90% at the lowest concentration tested to date in human lung cell lineContinue

OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract
CDC | COVID-19 | Life Science History

OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contract

On Jul. 20, 2020, BioReference Laboratories, an OPKO Health company, announced accepted an Indefinite Delivery Indefinite Quantity contract…

Read More OPKO Health’s BioReference Laboratories awarded commercial surge capacity testing for COVID-19 emergency response contractContinue

Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2
Life Science History | Vaccine

Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2

On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…

Read More Pfizer and BioNTech announced sgreement with the UK for 30 million doses of mRNA-based vaccine candidate against SARS-CoV-2Continue

Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
Life Science History | Vaccine

Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study

On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…

Read More Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine studyContinue

Thermo Fisher Scientific’s to support development and production of  COVID-19 therapeutics and vaccines
COVID-19 | Life Science History | Vaccine

Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccines

On Jul. 20, 2020, Thermo Fisher Scientific expanded global capacity and capabilities across its leading pharma services network…

Read More Thermo Fisher Scientific’s to support development and production of COVID-19 therapeutics and vaccinesContinue

Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
COVID-19 | FDA | Life Science History

Luminex received FDA Emergency Use Authorization for COVID-19 antibody test

On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPᆴ…

Read More Luminex received FDA Emergency Use Authorization for COVID-19 antibody testContinue

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection
COVID-19 | Life Science History | Nanotechnology | Vaccine

HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injection

On Jul. 20, 2020, scientists at HDT Bio, PAI Life Sciences, and the University of Washington announced they…

Read More HDT BIOメs COVID-19 vaccine candidate HDT-301 induced neutralizing antibody responses after single injectionContinue

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials
COVID-19 | Life Science History | Vaccine

HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trials

On Jul. 19, 2020, HDT Bio announced co-development efforts with Gennova Biopharmaceuticals to start evaluating HDT-301, a COVID-19…

Read More HDT Bio partnered with Gennova Biopharmaceuticals to bring COVID-19 vaccine to human trialsContinue

Page navigation

Previous PagePrevious 1 … 138 139 140 141 142 … 348 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search